Bemarituzumab [CAS 1952272-74-0]
Partner: MedChemexpress LLC
CAS No: | 1952272-74-0 |
Applications: | Cancer-Kinase/protease |
MW: | N/A |
Formula: | N/A |
SMILES: | [Bemarituzumab] |
Purity: | 99.50 |
Description: | Bemarituzumab is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research[1]. |
Shipping Conditions: | Ship on dry ice |
Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice